Twelve weeks of treatment with the agent, called rosnilimab, led to a…
Source link : https://www.medpagetoday.com/meetingcoverage/acr/118229
Author :
Publish date : 2025-10-30 15:22:00
Copyright for syndicated content belongs to the linked Source.
T-Cell Killer Opens New Approach to Rheumatoid Arthritis
Source link : https://www.medpagetoday.com/meetingcoverage/acr/118229
Author :
Publish date : 2025-10-30 15:22:00
Copyright for syndicated content belongs to the linked Source.